 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 2312 | 回復(fù): 11 | |||||
| 當(dāng)前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||||
[交流]
GSK被調(diào)查，會對醫(yī)藥行業(yè)各個產(chǎn)業(yè)鏈產(chǎn)生什么影響 已有11人參與
|
|||||
| 大家都來深入淺出的分析一下 |
回復(fù)此樓» 收錄本帖的淘帖專輯推薦
 新藥研發(fā)必備資料 | 行業(yè)動態(tài) |
» 猜你喜歡
提取腫瘤組織消化后得到的腫瘤細胞死亡率過高
已經(jīng)有0人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
藥理學(xué)論文潤色/翻譯怎么收費?
已經(jīng)有57人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
有償求腸毒素的脆弱擬桿菌（ETBF）
已經(jīng)有0人回復(fù)
-
跪求一支AAV293細胞
已經(jīng)有1人回復(fù)
» 本主題相關(guān)商家推薦: (我也要在這里推廣)
醉臥西風(fēng)
銀蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1484.3
- 紅花: 2
- 帖子: 794
- 在線: 125.5小時
- 蟲號: 777276
- 注冊: 2009-05-22
- 專業(yè): 有機合成
5樓2013-07-17 19:26:08
cydwood
金蟲 (小有名氣)
- 應(yīng)助: 3 (幼兒園)
- 金幣: 1146
- 帖子: 164
- 在線: 100.3小時
- 蟲號: 536376
- 注冊: 2008-03-30
- 性別: GG
- 專業(yè): 有機合成
2樓2013-07-17 13:17:45
buffalo2012
銀蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1957.5
- 帖子: 61
- 在線: 73.8小時
- 蟲號: 1636297
- 注冊: 2012-02-23
- 專業(yè): 細胞信號轉(zhuǎn)導(dǎo)
★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
|
柳葉刀文章，轉(zhuǎn)自丁香園，分析GSK事件，說中國醫(yī)患問題可能與醫(yī)生和某些藥企的不健康關(guān)系有關(guān)，請看下文： Doctors and pharma in China The Lancet Doctor—patient relationships in China are in crisis. Doctors have been injured or even killed by patients at work. One of the major drivers might be the unhealthy and unethical relations between many doctors and some drug companies. On July 8, GlaxoSmithKline (GSK) said that they were investigating allegations that its staff had improperly used cash and other incentives to encourage the prescription of onabotulinumtoxin A (Botox) in China. The company added that “inquiries to date have found no evidence of bribery or corruption in relation to our sales and marketing of therapeutic Botox in China.” The Lancet has no evidence to suggest that the allegations against GSK in China are true. However, some observers claim that bribing doctors to boost drug prescriptions by some drug companies is an open secret, and that this alleged practice has compromised the public's trust in doctors. The varieties of unethical relationships that exist between some doctors and some of the drug companies in China are said to range from cash kickbacks, lavish gifts or entertainment, ghost writing services, sponsored supplements in journals, and all-expenses-paid trips. There is real concern that doctors' prescriptions are therefore not based solely on patient need and clinical evidence, but may be biased by commercial interests. The perceived unethical association between physicians and industry in China is worrying, because it inevitably harms patients as well as doctors. It damages the doctor—patient relationship and, ultimately, China's whole health system. The GSK China allegations, although unproven, have clearly rung an alarm bell for China's regulatory authorities to ensure the drug industry promotes products in a responsible, ethical, and professional way. Chinese doctors should rely on evidence-based clinical guidelines to inform their practice, and are in urgent need of guidance on their collaborations with the drug industry in various areas such as patient care, professional education, and research. Furthermore, training for doctors in China on managing their relationships ethically with the drug industry and other organisations should start at medical school and be part of continuing professional education. |
3樓2013-07-17 14:31:18
先是網(wǎng)上報紙上罵聲一片，然后磚家出來澄清，然后。。。。。就沒有然后了。 4樓2013-07-17 14:33:25
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 08工科求調(diào)劑286 +5 | tgs_001 2026-03-28 | 5/250 |
|
|---|---|---|---|---|
|
|
[考研] 085601 329分調(diào)劑 +4 | yzsa12 2026-03-31 | 4/200 |
|
|
|
[考研] 理學(xué)07化學(xué) 303求調(diào)劑 +4 | 睿08 2026-03-27 | 4/200 |
|
|
|
[考研] 求調(diào)劑，一志愿 南京航空航天大學(xué) ，080500材料科學(xué)與工程學(xué)碩，總分289分 +9 | @taotao 2026-03-29 | 9/450 |
|
|
|
[考研] 一志愿北京化工大學(xué)材料與化工（085600）296求調(diào)劑 +25 | 稻妻小編 2026-03-26 | 25/1250 |
|
|
[考研] 322求調(diào)劑 +10 | 宋明欣 2026-03-27 | 10/500 |
|
|
|
[考研] 348求調(diào)劑 +6 | 小懶蟲不懶了 2026-03-28 | 6/300 |
|
|
|
[考研] 295求調(diào)劑 +5 | wei-5 2026-03-26 | 5/250 |
|
|
|
[考研] 329求調(diào)劑 +10 | 鈕恩雪 2026-03-25 | 10/500 |
|
|
|
[考研] 081200-11408-276學(xué)碩求調(diào)劑 +6 | 崔wj 2026-03-26 | 6/300 |
|
|
|
[考研] 11408軟件工程求調(diào)劑 +3 | Qiu學(xué)ing 2026-03-28 | 3/150 |
|
|
|
[考研] 086502化學(xué)工程342求調(diào)劑 +6 | 阿姨復(fù)古不過 2026-03-27 | 6/300 |
|
|
|
[考研] 275求調(diào)劑 +10 | jjjjjjjjjjl 2026-03-27 | 10/500 |
|
|
|
[考研] 一志愿上海理工能源動力（085800）310分求調(diào)劑 +3 | zhangmingc 2026-03-27 | 4/200 |
|
|
|
[考研] 一志愿南師大0703化學(xué) 275求調(diào)劑 +4 | Ripcord上岸 2026-03-27 | 4/200 |
|
|
|
[考研] 考研調(diào)劑 +10 | 呼呼？~+123456 2026-03-24 | 10/500 |
|
|
|
[考研] 求調(diào)劑 +6 | 林之夕 2026-03-24 | 6/300 |
|
|
|
[考研]
 085602化學(xué)工程求調(diào)劑。
+4
|
平樂樂樂 2026-03-26 | 4/200 |
|
|
|
[考研] 一志愿北化315 求調(diào)劑 +3 | akrrain 2026-03-24 | 3/150 |
|
|
|
[考研] 277分求調(diào)劑，跨調(diào)材料 +3 | 考研調(diào)劑lxh 2026-03-24 | 3/150 |
|